Seoul Hosts Global Drug Regulators
Heads of pharmaceutical regulatory agencies from 30 countries around the world, including the United States, the European Union and Japan, will gather in Seoul to explore ways to innovate the future pharmaceutical regulatory system. The Ministry of Food and Drug Safety said it will host the Internat
Seoul will host a global gathering of pharmaceutical regulatory agency heads from 30 countries, including the United States, European Union and Japan, from November 3 to 6. The International Coalition of Medicines Regulatory Authorities (ICMRA) Summit and Assembly at Conrad Seoul aims to innovate the future regulatory system. This marks the first major international conference held in South Korea since joining ICMRA in 2013 and follows the country's recent election to the ICMRA Management Committee for 2026-2029.
The Management Committee, comprising 13 authorities from 11 countries, includes the chair nation Australia, the United States and the European Union. Key attendees will include the European Medicines Agency's Emer Cooke and Japan's Pharmaceuticals and Medical Devices Agency CEO Yasuhiro Fujiwara. The conference will feature three main sessions addressing AI in pharmaceutical regulation, new approach methodologies (NAMs) that use AI and organoids for animal testing replacement, and strengthening patient-centered drug development frameworks.
The Ministry of Food and Drug Safety co-chairs the AI session with Singapore's Health Sciences Authority and leads discussions. The ministry also plans bilateral meetings with major regulatory authorities to discuss cooperation tasks for overseas expansion of domestic companies, including joint reviews, regulatory information exchanges, and strategic regulatory diplomacy.
Written by urgent.news from BusinessKorea's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
